BNP immunoassays. We found better agreement between the results obtained with the IRMA and ADVIA methods ( Fig. 1D ; see also Fig. 1D in the online Data Supplement). We also observed a significant difference between the results obtained with these two methods (P ϭ 0.0032); the mean (SD) difference was 2.1 (140.8) ng/L.
. Resistance to rifampin, one of the most efficient antitubercular drugs, is conferred mainly by mutations in the rpoB gene. Ninetysix percent of rifampin-resistant cases are attributable to point mutations, insertions, or deletions located in an 81-nucleotide segment of the rpoB gene (5 ) . Although resistance to isoniazid can be conferred by mutations in several different genes, mutations in katG represent the most frequent cause of the resistance (3, 6 ) . Here we describe the allele-specific depletory PCR (ASD-PCR) assay, which was developed for the detection of mutations associated with M. tuberculosis resistance to first-line drugs, specifically isoniazid and rifampin.
The accuracy and reproducibility of classic allele-specific PCR assays depend greatly on the careful selection of amplification conditions, primer design, and template concentration. Elongation through the mismatched duplex leads to accumulation of mutant template fully complementary to the initially mismatched primer, yielding the false-positive amplicon. Depending on the nature of the mismatch composition, the elongation efficiency of the mismatched duplex in a single round of PCR can vary from 0.0001% to 1% of the elongation efficiency of the perfectly matched duplex (7 ). We found that inclusion of an additional "auxiliary" pair of primers amplifying an arbitrarily chosen conserved region of the M. tuberculosis genome concurrently with the allele-specific PCR reaction efficiently suppresses unwanted amplification from the 3Ј-terminally mismatched allelic primer. The auxiliary primer pair always forms perfect duplexes with complementary regions of DNA, thereby yielding efficient amplification of M. tuberculosis DNA fragments unrelated to the target sequence. If both allele-specific and auxiliary primer pairs match perfectly to the DNA, efficient accumulation of both amplicons takes place in the same tube. In cases in which the allele-specific primer forms 3Ј-terminal mismatches, auxiliary amplicon accumulates with much greater efficiency (Fig. 1A) .
Many of the techniques designed for the identification of bacilli of the M. tuberculosis complex rely on detection of the IS6110 element (8 ) . A species-specific genetic marker of M. tuberculosis, mtp40, has been described (9 ) . Use of this genetic marker as an auxiliary amplicon in the ASD-PCR assay permits identification of the organism as either M. tuberculosis (using mtp40 as marker) or another M. tuberculosis complex bacterium (using IS6110 as the marker), while simultaneously identifying mutations conferring drug resistance. Although there are several indications that the sequence of mtp40 can be disrupted by IS6110 insertion (10 ) and that mycobacteria outside of the M. tuberculosis complex can harbor IS6110 (11 ), such exceptions can be considered as rare. A 622-bp fragment of mtp40 and a 1085-bp part of the IS6110 element were elaborated as auxiliary amplicons.
The PCR mixture contained 0. 
Production of allelic and auxiliary amplicons in the same PCR reaction leads to competition between the amplicons for polymerase and dNTPs. Introduction of additional amplicons causes depletion of major reaction components before the amount of the amplicon extended from the 3Ј-terminally mismatched primer reaches a significant concentration. We speculated that lowering the concentrations of the input dNTPs renders the ASD-PCR assay specificity virtually independent from the amount of the input DNA template. The optimum range of dNTP concentrations, in which efficient and specific PCR still occurs while accumulation of illegitimate product is suppressed, was determined empirically to be 30 -50 M (data not shown). At higher dNTP concentrations, accumulation of the misprimed amplicon is possible during late cycles of PCR. The results (Fig. 1B) showed that under optimized conditions, accrual of the auxiliary amplicon efficiently suppressed accumulation of the false-positive PCR product. Under the same conditions, conventional allele-specific PCR assays showed dramatically reduced reliability, whereas the ASD-PCR assay with either of the auxiliary amplicons completely retained the capacity to differentiate between alleles. Thus, with an ASD-PCR assay, results can be obtained at the stage when all reactions reach their plateaus. Although the time in which the amplicon amount reaches plateau depends on the concentration of the input template, this concentration can be ignored in the analysis of amplification data at the late cycles of the PCR.
To determine whether the power of the ASD-PCR assay to differentiate between alleles depended on the amount of the input genomic DNA, we set up a series of ASD-PCR reactions with the amount of input DNA varying from 10 pg to 100 ng. The auxiliary amplicon used was the 622-bp fragment of the mtp40. As shown in Fig. 1 of the online Data Supplement, the ASD-PCR assay remained specific in the range of template concentrations spanning at least five orders of magnitude. Under the described conditions, the method permitted efficient mutation detection with as little as 10 pg of input genomic DNA.
We used the ASD-PCR assay for identification of seven point mutations responsible for most of the drug-resistant tuberculosis cases encountered in reference clinics in Russia (13, 14 ) . Six mutations in the rpoB gene (D516V, H526D, H526Y, H526R, H526L, and S531L) and one mutation in the katG gene (S315T) were interrogated. Using the ASD-PCR assay, we achieved highly accurate detection of the katG S315T mutation, which accounts for Ͼ90% of isoniazid resistance in Russia (15 ) . Detection of six mutations in the rpoB gene, which together are responsible for ϳ90% of rifampin resistance (14, 15 ) Table 1 in the online Data Supplement). Typical results of the ASD-PCR assay are presented in Fig. 1C . The ASD-PCR results were in perfect agreement with the sequencing and microbiological data.
ASD-PCR can be used for detection of drug-resistant isolates in a background of wild-type bacilli. We investigated the detection limit of the ASD-PCR assay for identifying the mutant M. tuberculosis present as the minor subpopulation against a background of wild-type bacilli. Wild-type (H37Rv) and mutant DNAs were mixed at different ratios (0 -100%) and subjected to ASD-PCR. Reactions were carried out for 50 cycles with 10 ng of DNA mixture. Our results suggest that for all seven mutations analyzed, the ASD-PCR method permits detection of least 5% mutant sequences in the DNA sample (see Fig. 1D ). This sensitivity approaches that of amplification refractory mutation system (17 ) and phenotypic methods.
In conclusion, development of fast, economical, and technically affordable molecular techniques, such as ASD-PCR, for detection of drug-resistant tuberculosis would facilitate the rapid response required to limit the extent and severity of multiple drug-resistant tuberculosis (MDR-TB) transmission and infection, decrease the incidence of primary MDR-TB, and improve the care of patients with MDR-TB in a cost-effective manner. The , sensitivity of ASD-PCR for analysis of mixed populations consisting of wild-type and mutant DNA species. DNA of M. tuberculosis H37Rv and a clinical isolate containing the rpoB D516V mutation were mixed at different ratios and subjected to ASD-PCR. Primer set wt516a, specific to the wild-type rpoB, and primer set mt516t, specific to the D516V rpoB mutant, were used in gels 1 and 2, respectively. AS, allelic amplicon; IS6110 and mtp40, auxiliary amplicons; M, 100-bp DNA ladder. ASD-PCR assay described here can be easily adapted for the identification of other drug-resistant mutations in M. tuberculosis. It can also serve as a simple and efficient tool for general single-nucleotide polymorphism analysis. Laboratory analytes for individuals are subject to several sources of variation, including biological variation, preanalytical variation (specimen collection), analytical variation (bias and imprecision), and postanalytical variation (reporting of results). Biological variation consists of within-person (WP) and between-person (BP) variation. These components of biological variation are used to set analytical quality specifications for bias and imprecision, evaluate serial changes in individual analytes, and assess the clinical utility of population-based reference intervals.
Estimate of Biological Variation of Laboratory Analytes
Desirable quality specifications for imprecision (I), bias (B), and total error have been related to the WP CV (CV w ) and the BP CV (CV g ) of laboratory analytes (1-3 ) . Imprecision should be ideally less than one half of the CV W , and bias should be Ͻ0.25
1/2 . The quality specification for total error is to be less than kI ϩ B, where k ϭ 1.65 at ␣ ϭ 0.05. The total CV (CV t ) can be estimated assuming that the CVs of all sources are measured at the same analyte mean and that pre-and postanalytical sources of variation are negligible. The CV t ϭ [(CV a ) 2 ϩ (CV w ) 2 ] 1/2 , where the analytical CV (CV a ) equals the laboratory method imprecision (CV i ) if there is no bias present.
Estimates of CV w and CV g for laboratory analytes were derived from the Third National Health and Nutrition Examination Survey (NHANES III) conducted from 1988 to 1994 (4, 5 ) . NHANES III was a cross-sectional survey that collected data on the civilian noninstitutionalized US population through questionnaires and medical examinations, including laboratory analytes. NHANES III used a stratified, multistage probability design to collect a nationally representative sample. The laboratory methods including imprecision (CV i ) for NHANES III have been described (6 ) .
The BP and WP means, SDs, and CVs for 42 general biochemical, nutritional, immunologic, environmental, and hematologic analytes are listed in Table 1 . The BP and WP variations were estimated on 24 978 and 2426 sample persons, respectively. The WP sample, ϳ10% of the sample persons, was recruited for a second analyte measurement. The WP sample was not selected randomly, but with the goal for obtaining approximately equal proportions of males and females with one half between 20 and 39 years of age and one half over 40 years of age. When possible, the second examinations were scheduled at the same time of day as the first examinations. Compared with the BP sample, the WP sample was older (mean age, 42.9 vs 30.8 years), had more non-Hispanic whites (42.2%
